Gene mutations in acute myeloid leukemia (AML) cells can guide treatment options, and machine learning can rapidly guess the ...

Actimab-A is a humanized anti-CD33 antibody conjugated to Actinium-225 (Ac-225). With its potent alpha-particle payload ...

New research led by scientists at VCU Massey Comprehensive Cancer Center suggests that a class of drugs known as MCL-1 (myeloid leukemia cell-1) inhibitors interact with a type of kinase inhibitor ...

The new findings are the first to describe distributions and perturbations of low-density granulocyte and normal-density ...

Increased mixed chimerism, as detected by AlloHeme, could predict post-transplant relapse “with a high degree of accuracy,” said Monzr M. Al Malki, MD.

A federal jury ruled on Friday that New Orleans jeweler Mignon Faget discriminated against a pregnant woman who requested family leave while employed by the company, according to court records.

A new study has identified a critical mechanism that could lead to substantial advancements in the treatment of acute myeloid leukemia (AML).

Scientists have supercharged CAR-T therapy, making it more powerful against elusive cancer cells that usually escape ...

4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells ... of acute myeloid leukemia and ...

and cell death. Abnormalities in tyrosine kinases are common in AML, and constitute an attractive therapeutic target. An example is given by the balanced chromosomal translocations (TEL-Abl ...